Reinaldo M. Diaz

Reinaldo M. Diaz is a seasoned financial and management professional with extensive board and executive experience in the biotechnology and investment sectors. Currently serving as a Board Member for LEXEO Therapeutics and Inozyme Pharma, Diaz also holds the position of Managing Director at DA Advisors, LLC. Previous roles include Venture Partner at Longitude Capital Management and Managing Director at C.T. Services Americas, Inc., and Celtic Pharma Management, L.P. Diaz co-founded Diaz & Altschul Capital Management, LLC, where a significant part of the career was dedicated to finance and investment strategy. Educational qualifications include an MBA from Harvard Business School and a BA in Economics from Harvard University.